2026 NPPES data Dermatology Physician NPI 1457465932 M. D.
Verify on CMS →

ROXANN POWERS, M. D.

Dermatology Physician in MORGANTOWN, West Virginia. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
327
Medicare Part D claims · 119 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
94.1061/100
▲ 11 pts above national avg 83.1 · [object Object]

What the federal data shows

ROXANN POWERS, M. D. reported a CMS MIPS final score of 94.1061/100 — above the 83.1 national average — and filed 327 Medicare Part D claims in 2023.

94.1061/100
MIPS score · +11 vs avg
327
Part D claims, 2023
91%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ROXANN POWERS, M. D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

94 Top 25% higher than 75% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

ROXANN POWERS, M. D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ROXANN POWERS, M. D.?

High performer (top quartile)

NPI registry status

Active

Issued 08/19/2006

NPI 1457465932

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

327 55% vs specialty avg

2023 prescription claims

Specialty avg: 729

MIPS final score

94.1061/100 11.006100000000004% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in West Virginia

How Dermatology Physician compares to other specialties among West Virginia providers

West Virginia providers

Dermatology Physician share within West Virginia

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within West Virginia

Medicare quality performance — MIPS

ROXANN POWERS, M. D.'s 2023 MIPS final score plotted against the Dermatology Physician national average

High performer (top quartile)
MIPS Final Score
94.1061/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Dermatology Physician) — 94.1061/100 vs national avg 83.1

0%100%National avg83%94.1%
MIPS final score (Dermatology Physician) — 94.1061/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ROXANN POWERS, M. D. appears in the CMS NPPES registry as a Dermatology Physician provider holding M. D. credentials at 1 STADIUM DRIVE, MORGANTOWN, WV, 26506, with a listed phone of (304) 598-4800. NPI 1457465932 was issued on 08/19/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what POWERS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 327 prescription claims written by this provider, covering 119 Medicare beneficiaries and totaling roughly $124K in drug spend, split 9% brand-name and 91% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 94.1061/100 for the 2023 performance year (Quality 78.4655), compared with the national average of 83.1.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1 STADIUM DRIVE
MORGANTOWN, WV 26506

Provider Details

NPI 1457465932
Specialty Dermatology Physician
Credentials M. D.
Gender Female
NPI Issued 08/19/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

94.1061
Final Score
Avg: 83.1
78.4655
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Brand vs generic prescribing mix · Generic-heavy

ROXANN POWERS, M. D. — brand share 9.0%
Specialty average (est.)

9% brand-name claims vs 91% generic, on 327 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

327
Total Claims
$124K
Total Drug Cost
119
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
427
Total Day Supply
11,526
Brand vs Generic
9% brand / 91% generic
Brand Drug Cost
$111K
Generic Drug Cost
$13K
Antibiotic Claims
33

Patient Demographics

Average Patient Age
73.3 years
Avg HCC Risk Score
1.25
Gender Split
64% female / 36% male
Age Distribution
<65: 11, 65-74: 51, 75-84: 46, 85+: 11

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ROXANN POWERS, M. D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ketoconazole
81
Triamcinolone Acetonide
54
Clobetasol Propionate
36
Fluocinolone Acetonide
Fluocinolone/Shower Cap
25
Metronidazole
16
Doxycycline Monohydrate
15
Fluorouracil
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How ROXANN POWERS, M. D. fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

ROXANN POWERS, M. D.'s 327 claims are below the specialty average of 729.

Nearby Dermatology Physician Providers in West Virginia

Other clinicians with the same primary specialty enrolled in West Virginia, drawn from the same CMS NPPES roster as POWERS.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ROXANN POWERS, M. D.'s specialty?
ROXANN POWERS, M. D. specializes in Dermatology Physician and practices in MORGANTOWN, West Virginia. Credentials: M. D..
How much does ROXANN POWERS, M. D. prescribe under Medicare Part D?
In 2023, ROXANN POWERS, M. D. wrote 327 Medicare Part D claims totaling $124K in drug costs for 119 beneficiaries.
What is ROXANN POWERS, M. D.'s Medicare quality score?
ROXANN POWERS, M. D. has a CMS MIPS Final Score of 94.1061/100 (Quality: 78.4655). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ROXANN POWERS, M. D. located?
ROXANN POWERS, M. D. is located at 1 STADIUM DRIVE, MORGANTOWN, WV, 26506. Phone: (304) 598-4800.
What is ROXANN POWERS, M. D.'s NPI number?
ROXANN POWERS, M. D.'s National Provider Identifier (NPI) is 1457465932, issued on 08/19/2006.
Does ROXANN POWERS, M. D. prescribe more brand-name or generic drugs?
ROXANN POWERS, M. D.'s prescribing is 9% brand-name and 91% generic drugs by claim count, with $111K in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does ROXANN POWERS, M. D. prescribe most often?
Based on 2023 Medicare Part D data, ROXANN POWERS, M. D.'s most frequently prescribed drugs include Ketoconazole, Triamcinolone Acetonide, Clobetasol Propionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ROXANN POWERS, M. D. accept Medicare?
ROXANN POWERS, M. D. appears in CMS Medicare data with 327 Part D claims and 119 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ROXANN POWERS, M. D.'s credentials?
ROXANN POWERS, M. D.'s NPI is 1457465932 with credentials M. D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology